EP4027815

COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    14.8.2020
  • EP published:
    15.4.2026
  • EP application number:
    20862843.8
  • Max expiry date:
    13.8.2040
  • Expiry date:
    13.8.2026
  • Title in English:
    COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
  • Language of the patent:
    English

Timeline

Today
14.8.2020EP application
15.4.2026EP Publication
13.8.2026Expires

Owner

  • Name:
    Achieve Life Sciences, Inc.
  • Address:
    520 Pike Street, Suite 2250, Seattle, WA 98101, US

Inventor

  • Name:
    JACOBS, Cindy, A.
  • Address:
    Fall City, WA 98024, US
  • Name:
    CAIN, Daniel, F.
  • Address:
    Vashon, WA 98070, US
  • Name:
    CLARKE, Anthony
  • Address:
    Checkendon RG8 0TD, GB

Priority

  • Number:
    201962899637 P
  • Date:
    12.9.2019
  • Country:
    US
  • Number:
    202062988890 P
  • Date:
    12.3.2020
  • Country:
    US

Classification

  • Categories:
    A61K 31/439, A61K 31/465, A24B 15/16, A61K 9/00, A61P 25/34

Upload documents